AnaptysBio, Inc. (ANAB)
45.95
-0.26
(-0.56%)
USD |
NASDAQ |
Oct 09, 16:00
46.00
+0.05
(+0.11%)
Pre-Market: 20:00
AnaptysBio Total Liabilities (Quarterly) : 335.42M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 335.42M |
| March 31, 2026 | 316.94M |
| December 31, 2025 | 327.18M |
| September 30, 2025 | 382.51M |
| June 30, 2025 | 379.98M |
| March 31, 2025 | 388.03M |
| December 31, 2024 | 412.97M |
| September 30, 2024 | 409.05M |
| June 30, 2024 | 417.50M |
| March 31, 2024 | 358.06M |
| December 31, 2023 | 364.29M |
| September 30, 2023 | 366.94M |
| June 30, 2023 | 368.65M |
| March 31, 2023 | 360.70M |
| December 31, 2022 | 348.28M |
| September 30, 2022 | 340.88M |
| June 30, 2022 | 299.54M |
| March 31, 2022 | 294.42M |
| December 31, 2021 | 286.64M |
| September 30, 2021 | 40.73M |
| June 30, 2021 | 40.84M |
| March 31, 2021 | 14.48M |
| December 31, 2020 | 19.82M |
| September 30, 2020 | 24.51M |
| Date | Value |
|---|---|
| June 30, 2020 | 20.31M |
| March 31, 2020 | 23.67M |
| December 31, 2019 | 30.19M |
| September 30, 2019 | 30.61M |
| June 30, 2019 | 31.73M |
| March 31, 2019 | 26.07M |
| December 31, 2018 | 22.63M |
| September 30, 2018 | 23.44M |
| June 30, 2018 | 21.04M |
| March 31, 2018 | 20.31M |
| December 31, 2017 | 21.78M |
| September 30, 2017 | 20.59M |
| June 30, 2017 | 21.23M |
| March 31, 2017 | 21.00M |
| December 31, 2016 | 22.91M |
| September 30, 2016 | 12.29M |
| June 30, 2016 | 14.10M |
| March 31, 2016 | 12.94M |
| December 31, 2015 | 13.94M |
| September 30, 2015 | 15.30M |
| June 30, 2015 | 16.44M |
| March 31, 2015 | 17.09M |
| December 31, 2014 | 19.07M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 346.01M |
| Shareholders Equity (Quarterly) | 10.58M |
| Debt to Equity Ratio | 25.47 |
| Current Ratio | 5.613 |
| Net Debt Paydown Yield | 0.76% |